603367 辰欣药业
已收盘 09-14 15:00:00
资讯
新帖
简况
辰欣药业(603367.SH)子公司药品氯替泼诺妥布霉素滴眼液首仿获批上市
智通财经 · 16:05
辰欣药业(603367.SH)子公司药品氯替泼诺妥布霉素滴眼液首仿获批上市
每周股票复盘：辰欣药业（603367）每股派现0.216元
证券之星 · 09-13 02:27
每周股票复盘：辰欣药业（603367）每股派现0.216元
辰欣药业（603367）披露2026年半年度权益分派实施公告，9月8日股价上涨2.27%
证券之星 · 09-08
辰欣药业（603367）披露2026年半年度权益分派实施公告，9月8日股价上涨2.27%
每周股票复盘：辰欣药业（603367）上半年净利增15.40%
证券之星 · 09-06
每周股票复盘：辰欣药业（603367）上半年净利增15.40%
辰欣药业（603367）披露2026年半年度业绩暨现金分红说明会召开情况，9月2日股价下跌0.67%
证券之星 · 09-02
辰欣药业（603367）披露2026年半年度业绩暨现金分红说明会召开情况，9月2日股价下跌0.67%
辰欣药业（603367）2026年中报简析：净利润同比增长15.4%
证券之星 · 08-26
辰欣药业（603367）2026年中报简析：净利润同比增长15.4%
辰欣药业(603367)6月30日股东户数3.8万户，较上期减少9.72%
证券之星 · 08-25
辰欣药业(603367)6月30日股东户数3.8万户，较上期减少9.72%
图解辰欣药业中报：第二季度单季净利润同比增长56.16%
证券之星 · 08-24
图解辰欣药业中报：第二季度单季净利润同比增长56.16%
辰欣药业2026年半年报：净利依赖非经常损益，主业盈利承压
蓝鲸财经 · 08-24
辰欣药业2026年半年报：净利依赖非经常损益，主业盈利承压
每周股票复盘：辰欣药业（603367）本周现两笔大宗交易
证券之星 · 05-31
每周股票复盘：辰欣药业（603367）本周现两笔大宗交易
股市必读：5月28日辰欣药业现808.3万元大宗交易
证券之星 · 05-29
股市必读：5月28日辰欣药业现808.3万元大宗交易
辰欣药业（603367）披露2025年年度权益分派实施公告，5月28日股价下跌1.01%
证券之星 · 05-28
辰欣药业（603367）披露2025年年度权益分派实施公告，5月28日股价下跌1.01%
每周股票复盘：辰欣药业（603367）将参加投资者网上集体接待日活动
证券之星 · 05-17
每周股票复盘：辰欣药业（603367）将参加投资者网上集体接待日活动
辰欣药业（603367）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.77%
证券之星 · 05-13
辰欣药业（603367）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.77%
辰欣药业（603367）披露2025年年度股东会决议公告，5月8日股价下跌0.06%
证券之星 · 05-08
辰欣药业（603367）披露2025年年度股东会决议公告，5月8日股价下跌0.06%
每周股票复盘：辰欣药业（603367）股东户数下降6.82%，一季报净利降8.92%
证券之星 · 05-02
每周股票复盘：辰欣药业（603367）股东户数下降6.82%，一季报净利降8.92%
辰欣药业（603367）2026年一季报简析：净利润同比下降8.92%
证券之星 · 04-30
辰欣药业（603367）2026年一季报简析：净利润同比下降8.92%
辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%
智通财经 · 04-28
辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%
每周股票复盘：辰欣药业（603367）股东减持136.83万股完成
证券之星 · 04-19
每周股票复盘：辰欣药业（603367）股东减持136.83万股完成
辰欣药业（603367）披露股东减持计划实施完毕公告，4月16日股价下跌0.37%
证券之星 · 04-16
辰欣药业（603367）披露股东减持计划实施完毕公告，4月16日股价下跌0.37%
暂无数据
公司概况
公司名称：
辰欣药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-09-29
主营业务：
辰欣药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是普通输液、营养型输液、抗感染类药物、心脑血管类药物、肝病用药、消化系统药物、抗肿瘤及辅助用药。公司为中国化学制药工业百强企业和山东省首批“十强”产业集群领军企业。
发行价格：
11.66
{"stockData":{"symbol":"603367","market":"SH","secType":"STK","nameCN":"辰欣药业","latestPrice":14.16,"timestamp":1789369201000,"preClose":14,"halted":0,"volume":4077271,"delay":0,"changeRate":0.0114,"floatShares":453000000,"shares":453000000,"eps":1.0084,"marketStatus":"已收盘","change":0.16,"latestTime":"09-14 15:00:00","open":13.9,"high":14.16,"low":13.87,"amount":57263600,"amplitude":0.0207,"askPrice":14.16,"askSize":366,"bidPrice":14.15,"bidSize":252,"shortable":0,"etf":0,"ttmEps":1.0084,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":14,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":15.4,"lowLimit":12.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":452754129,"isCdr":false,"pbRate":1,"roa":"--","peRate":14.042047,"roe":"4.18%","epsLYR":0.93,"committee":0.200376,"marketValue":6411000000,"turnoverRate":0.009,"status":0,"floatMarketCap":6411000000},"requestUrl":"/m/hq/s/603367/tweets","defaultTab":"tweets","newsList":[{"id":"2667656246","title":"辰欣药业(603367.SH)子公司药品氯替泼诺妥布霉素滴眼液首仿获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656246","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667656246?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:05","pubTimestamp":1789373101,"startTime":"0","endTime":"0","summary":"智通财经APP讯，辰欣药业(603367.SH)发布公告，近日，公司子公司山东辰欣佛都药业股份有限公司(简称“佛都药业”)收到国家药品监督管理局核准签发的氯替泼诺妥布霉素滴眼液《药品注册证书》。氯替泼诺妥布霉素滴眼液注册分类为化学药品4类，主要用于治疗对类固醇有反应的眼部炎症，及其伴随的或潜在的眼表面细菌感染。佛都药业氯替泼诺妥布霉素滴眼液首次提交注册申请获得受理的时间为2025年，本次为国内首仿上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","IPOS","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667074575","title":"每周股票复盘：辰欣药业（603367）每股派现0.216元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667074575","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667074575?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:27","pubTimestamp":1789237629,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，辰欣药业报收于14.0元，较上周的14.48元下跌3.31%。本周，辰欣药业9月8日盘中最高价报14.84元。9月11日盘中最低价报13.82元。辰欣药业当前最新总市值63.39亿元，在化学制药板块市值排名76/149，在两市A股市值排名2606/5218。本周关注点公司公告汇总：辰欣药业2026年半年度每股派发现金红利0.216元（含税）。本次利润分配以公司总股本452,754,129股为基数，共派发现金红利97,794,891.86元。分红对象为股权登记日在册的全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321816","title":"辰欣药业（603367）披露2026年半年度权益分派实施公告，9月8日股价上涨2.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321816","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665321816?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:57","pubTimestamp":1788861453,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，辰欣药业报收于14.84元，较前一交易日上涨2.27%，最新总市值为67.19亿元。辰欣药业于近日披露《2026年半年度权益分派实施公告》。公告显示，公司2026年半年度利润分配方案为：每股派发现金红利0.216元（含税），股权登记日为2026年9月15日，除权（息）日和现金红利发放日均为2026年9月16日。本次利润分配以公司总股本452,754,129股为基数，共派发现金红利97,794,891.86元。分红对象为股权登记日在册的全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665036514","title":"每周股票复盘：辰欣药业（603367）上半年净利增15.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665036514","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665036514?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:07","pubTimestamp":1788631632,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，辰欣药业报收于14.48元，较上周的14.85元下跌2.49%。本周，辰欣药业9月1日盘中最高价报15.1元。9月4日盘中最低价报14.38元。辰欣药业当前最新总市值65.56亿元，在化学制药板块市值排名76/149，在两市A股市值排名2577/5214。公司拟每10股派发现金红利2.16元（含税），已披露利润分配方案。会议通过网络文字互动方式进行，就业绩表现、分红计划等问题与投资者进行了交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664810147","title":"辰欣药业（603367）披露2026年半年度业绩暨现金分红说明会召开情况，9月2日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664810147","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664810147?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:54","pubTimestamp":1788360853,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，辰欣药业报收于14.9元，较前一交易日下跌0.67%，最新总市值为67.46亿元。近日，辰欣药业股份有限公司披露《关于2026年半年度业绩暨现金分红说明会召开情况的公告》。公告显示，公司于2026年9月2日召开2026年半年度业绩暨现金分红说明会，披露2026年上半年实现营业收入16.93亿元，同比下降2.68%；归母净利润2.64亿元，同比增长15.40%；扣非后净利润1.58亿元，同比下滑12.00%；经营现金流净额4.27亿元，同比增长20.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662049757","title":"辰欣药业（603367）2026年中报简析：净利润同比增长15.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662049757","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662049757?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:11","pubTimestamp":1787695901,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期辰欣药业发布2026年中报。根据财报显示，辰欣药业净利润同比增长15.4%。截至本报告期末，公司营业总收入16.93亿元，同比下降2.68%，归母净利润2.64亿元，同比上升15.4%。按单季度数据看，第二季度营业总收入8.43亿元，同比上升2.84%，第二季度归母净利润1.34亿元，同比上升56.16%。财报体检工具显示：建议关注公司应收账款状况本文数据来源于辰欣药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600009372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738596","title":"辰欣药业(603367)6月30日股东户数3.8万户，较上期减少9.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738596","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738596?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:38","pubTimestamp":1787650684,"startTime":"0","endTime":"0","summary":"证券之星消息，近日辰欣药业披露，截至2026年6月30日公司股东户数为3.8万户，较3月31日减少4090.0户，减幅为9.72%。在化学制药行业个股中，辰欣药业股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年3月31日至2026年6月30日，辰欣药业区间跌幅为22.88%，在此期间股东户数减少4090.0户，减幅为9.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661422025","title":"图解辰欣药业中报：第二季度单季净利润同比增长56.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661422025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661422025?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:14","pubTimestamp":1787566499,"startTime":"0","endTime":"0","summary":"证券之星消息，辰欣药业2026年中报显示，上半年度公司主营收入16.93亿元，同比下降2.68%；归母净利润2.64亿元，同比上升15.4%；扣非净利润1.58亿元，同比下降12.0%；其中2026年第二季度，公司单季度主营收入8.43亿元，同比上升2.84%；单季度归母净利润1.34亿元，同比上升56.16%；单季度扣非净利润4133.58万元，同比下降34.86%；负债率18.01%，投资收益9113.87万元，财务费用-940.33万元，毛利率54.57%。财报数据概要请见下图:本文数据来源于辰欣药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222765","title":"辰欣药业2026年半年报：净利依赖非经常损益，主业盈利承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222765","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661222765?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:39","pubTimestamp":1787564347,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月24日讯，8月24日，辰欣药业 公布2026年中报，公司依托“高端仿制药、创新药、OTC、特医食品”四轮驱动战略，在营收微降背景下实现净利润双位数增长，同时推出高额中期现金分红方案。财报数据显示，报告期公司实现营业收入16.93亿元，同比下降2.68%；归母净利润2.64亿元，同比增长15.40%；扣非归母净利润1.58亿元，同比下降12.00%。业绩变动的主要原因在于非经常性损益的影响。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787562283775069699","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639604945","title":"每周股票复盘：辰欣药业（603367）本周现两笔大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639604945?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:26","pubTimestamp":1780169170,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，辰欣药业报收于13.96元，较上周的14.45元下跌3.39%。本周，辰欣药业5月25日盘中最高价报14.48元。来自公司公告汇总：辰欣药业2025年年度权益分派实施，每股派发现金红利0.16元（含税），股权登记日为2026年6月2日。交易信息汇总5月27日辰欣药业发生1295.13万元大宗交易。5月28日辰欣药业发生808.3万元大宗交易。本次利润分配以公司总股本452,754,129股为基数，共派发现金红利72,440,660.64元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639613844","title":"股市必读：5月28日辰欣药业现808.3万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2639613844","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639613844?lang=zh_cn&edition=full","pubTime":"2026-05-29 02:39","pubTimestamp":1779993550,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，辰欣药业报收于13.71元，下跌1.01%，换手率1.16%，成交量5.25万手，成交额7221.31万元。当日关注点来自交易信息汇总：5月28日主力资金净流出354.86万元，占总成交额4.91%。来自交易信息汇总：当日发生808.3万元大宗交易。来自公司公告汇总：辰欣药业将于2026年6月3日实施2025年年度权益分派，每股派发现金红利0.16元（含税）。大宗交易5月28日辰欣药业现808.3万元大宗交易。本次利润分配以公司总股本452,754,129股为基数，共派发现金红利72,440,660.64元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900002259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638661626","title":"辰欣药业（603367）披露2025年年度权益分派实施公告，5月28日股价下跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638661626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638661626?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:34","pubTimestamp":1779960882,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，辰欣药业报收于13.71元，较前一交易日下跌1.01%，最新总市值为62.07亿元。该股当日开盘13.9元，最高13.98元，最低13.6元，成交额达7221.31万元，换手率为1.16%。辰欣药业股份有限公司于近日披露《2025年年度权益分派实施公告》。公告显示，本次利润分配以公司总股本452,754,129股为基数，每股派发现金红利0.16元（含税），共派发现金红利72,440,660.64元。股权登记日为2026年6月2日，除权（息）日与现金红利发放日均为2026年6月3日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800031644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636061457","title":"每周股票复盘：辰欣药业（603367）将参加投资者网上集体接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636061457?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:21","pubTimestamp":1778955669,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，辰欣药业报收于14.82元，较上周的15.67元下跌5.42%。本周，辰欣药业5月11日盘中最高价报15.93元。辰欣药业当前最新总市值67.1亿元，在化学制药板块市值排名81/150，在两市A股市值排名2852/5203。本周关注点来自公司公告汇总：辰欣药业将参加2026年5月15日举行的山东辖区上市公司投资者网上集体接待日活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635420017","title":"辰欣药业（603367）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635420017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635420017?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:57","pubTimestamp":1778666225,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，辰欣药业报收于15.42元，较前一交易日下跌0.77%，最新总市值为69.81亿元。辰欣药业股份有限公司近日发布《关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告》。公告显示，公司将于2026年5月15日15:00-16:30通过网络远程方式参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的“2026年山东辖区上市公司投资者网上集体接待日活动”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431374","title":"辰欣药业（603367）披露2025年年度股东会决议公告，5月8日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633431374?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:38","pubTimestamp":1778233137,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，辰欣药业报收于15.67元，较前一交易日下跌0.06%，最新总市值为70.95亿元。该股当日开盘15.68元，最高15.75元，最低15.58元，成交额达7081.4万元，换手率为1.0%。辰欣药业股份有限公司于近日披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月7日召开2025年年度股东会，出席会议的股东及代理人共400人，代表有表决权股份224,470,571股，占公司总股本的49.5789%。所有议案均获通过，无否决议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632284436","title":"每周股票复盘：辰欣药业（603367）股东户数下降6.82%，一季报净利降8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632284436","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632284436?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:31","pubTimestamp":1777671074,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，辰欣药业报收于15.55元，较上周的15.31元上涨1.57%。本周，辰欣药业4月29日盘中最高价报15.79元。股本股东变化股东户数变动截至2026年3月31日，辰欣药业股东户数为4.21万户，较12月31日减少3079.0户，减幅为6.82%。公司公告汇总辰欣药业股份有限公司第五届董事会第十三次会议决议公告辰欣药业股份有限公司于2026年4月28日召开第五届董事会第十三次会议，审议通过《关于公司2026年第一季度报告的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631452085","title":"辰欣药业（603367）2026年一季报简析：净利润同比下降8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631452085","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631452085?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:17","pubTimestamp":1777501038,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期辰欣药业发布2026年一季报。根据财报显示，辰欣药业净利润同比下降8.92%。截至本报告期末，公司营业总收入8.5亿元，同比下降7.59%，归母净利润1.31亿元，同比下降8.92%。去年的净利率为12.36%，算上全部成本后，公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000019609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630373990","title":"辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630373990","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630373990?lang=zh_cn&edition=full","pubTime":"2026-04-28 15:51","pubTimestamp":1777362682,"startTime":"0","endTime":"0","summary":"智通财经APP讯，辰欣药业(603367.SH)发布2026年第一季度报告，第一季度，公司实现营业收入8.5亿元，同比下降7.59%。归属于上市公司股东的净利润1.31亿元，同比下降8.92%。归属于上市公司股东的扣除非经常性损益的净利润1.17亿元，同比增长0.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628075980","title":"每周股票复盘：辰欣药业（603367）股东减持136.83万股完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2628075980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2628075980?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:21","pubTimestamp":1776536467,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，辰欣药业报收于16.02元，较上周的16.34元下跌1.96%。本周，辰欣药业4月15日盘中最高价报16.65元。本周关注点股本股东变化：江苏辰昕同泰减持136.83万股，占总股本0.3022%，计划实施完毕。公司公告汇总辰欣药业股份有限公司股东减持计划实施完毕暨股份减持结果公告本次减持计划实施前，江苏辰昕同泰企业管理有限公司持有辰欣药业股份1,368,286股，占总股本的0.302%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627295074","title":"辰欣药业（603367）披露股东减持计划实施完毕公告，4月16日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627295074","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627295074?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:27","pubTimestamp":1776331634,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，辰欣药业报收于16.35元，较前一交易日下跌0.37%，最新总市值为74.03亿元。该股当日开盘16.31元，最高16.39元，最低16.13元，成交额达1.25亿元，换手率为1.7%。公告显示，本次减持计划实施前，江苏辰昕同泰企业管理有限公司持有辰欣药业股份1,368,286股，占总股本的0.302%。截至2026年4月14日，江苏辰昕通过集中竞价方式累计减持1,368,286股，占公司总股本的0.302%，减持计划已实施完毕。本次实际减持情况与此前披露的减持计划一致，未违反相关承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789384176317,"stockEarnings":[{"period":"1week","weight":-0.0331},{"period":"1month","weight":-0.0909},{"period":"3month","weight":0.055},{"period":"6month","weight":-0.1713},{"period":"1year","weight":-0.3314},{"period":"ytd","weight":-0.1823}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辰欣药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"37974人(较上一季度减少9.72%)","perCapita":"11922股","listingDate":"2017-09-29","address":"山东省济宁市任城区高新区同济科技工业园","registeredCapital":"45275万元","survey":" 辰欣药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是普通输液、营养型输液、抗感染类药物、心脑血管类药物、肝病用药、消化系统药物、抗肿瘤及辅助用药。公司为中国化学制药工业百强企业和山东省首批“十强”产业集群领军企业。","listedPrice":11.66},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辰欣药业(603367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辰欣药业(603367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辰欣药业,603367,辰欣药业股票,辰欣药业股票老虎,辰欣药业股票老虎国际,辰欣药业行情,辰欣药业股票行情,辰欣药业股价,辰欣药业股市,辰欣药业股票价格,辰欣药业股票交易,辰欣药业股票购买,辰欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辰欣药业(603367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辰欣药业(603367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}